Director of the Centre of Excellence for Long-acting Therapeutics University of Liverpool
Injectable nanosuspensions are an effective platform for delivering poorly soluble small molecules and prodrugs over extended periods, from weeks to months from a single administration. This talk will explore the formation of injectable suspensions, and open questions regarding the missing physical science required to optimise future therapeutics. Examples of different clinical applications, including those in development, will demonstrate the potential scale of the impact of long-acting medicines and the wider benefits for global healthcare
Learning Objectives:
Understand the principles of injectable nanosuspensions and long-acting therapeutics including the pharmacological basis of extended pK profiles
Explore formulation strategies for small molecules and prodrugs that lead to candidate depot-forming formulations and prolonged systemic exposure
Evaluate clinical case studies demonstrating the impact of nanosuspension technology on patient outcomes across various therapeutic applications
Understand the wider benefits that long-acting therapeutics offers to society and the pharmaceutical industry
